A. Abstract
The Poultry Research Center Virus II (PRC II) is a replication-defective
avian sarcoma virus with envelope determinants of the A and B subgroups.
In nonproducing cells transformed by PRCII the products of the replicative
genes gag, pol, and env are not demonstrable, but a single polyprotein
of Mr 105,000 (p105) can be detected. PI 05 contains peptides of
the gag proteins p19 and p27 plus transformationspecific sequences.
It does not contain peptides of gPr95env of Pr180gag-pol (with the
possible exception of one pol peptide) .The transforma tion-specific
sequences of p105 are distinct form those of p100 of avian carcinoma
virus MH2, of pl10 coded for by avian myelocytoma virus MC29, and
of p75 or p40 of avian erythroblastosis virus AEV. They also show
no resemblance to p60src of Rous sarcoma virus. P105 is phosphorylated
on a tyrosine residue and has an associated phosphokinase activity.
P105 appears to be capable of autophosphorylation and of phosphorylating
homologous immunoglobulin.
B. Introduction
Until recently all avian sarcoma viruses were thought to have fundamentally
the same genetic structure. The investigated strains, chiefly Rous
sarcoma virus (RSV) and its relatives, contain an about 1.8-kilobase
(kb) insertion at the juncture of the env gene and the C region
(Duesberg and Vogt 1970; Wang et al. 1975). This transformation-specific
insertion, termed src, was found to be of cellular origin and to
code for a protein kinase of Mr 60,000 with preference for tyrosine
as a phosphoacceptor (Stehelin et al. 1976; Spector et al. 1978
; Brugge and Erikson 1977; Collett and Erikson 1978; Levinson et
al. 1978; Hunter and Sefton 1980). In contrast to RSV, avian acute
leukemia viruses code for polyproteins that are derived from a gene
in which gag sequences at the 5 I terminal part of the genome are
fused to transformation-specific, cell-derived sequences in the
middle of the genome. The cell-derived sequences form a substitution
for replicative information of the gag, po" and env genes (Bister
et al. 1977; Hu et al. 1979; Lai et al. 1979; Sheiness and Bishop
1979; Roussel et al. 1979; Sheiness et al. 1980). As a consequence
of this missing information, the acute avian leukemia viruses are
replication defective (Ishizaki and Shimizu 1970; Graf 1975 ; Bister
and Vogt 1978; Hu and Vogt 1979). A genome organization similar
to that of avian acute leukemia viruses has also been found in Abelson
and radiation leukemia virus of mice and in feline sarcoma virus
(Witte et al. 1978 ; Manteuil- Brutlag et al. 1980; Barbacid et
al. 1980; Sherr et al. 1980; Van de Ven et al. 1980). Recently a
new class of avian sarcoma viruses has been described which lack
src and have agenetic structure related to the avian acute leukemia
viruses (Breitman et al. 1981 ; Hanafusa et al. 1980; Kawai et al.
1980; Lee et al. 1980; Neil et al. 1981). The viruses belonging
to this group are Fujinami sarcoma virus (FSV), Y73, which is a
recent field isolate, and PRCII. Even though these viruses have
transformation-specific sequences which are different from the src
of RSV, their transformation-specific proteins bear some intriguing
functional resemblance to p60src. This functional similarity suggests
possible common elements in the mechanism of trans formation by
RSV and the new avian sarcoma viruses. The present paper will briefly
summarize our studies on PRCII as an eample of the new class of
avian sarcoma viruses (Breitman et al. 1981; Neil et al. 1981).
C. Results
PRCII was isolated from a spontaneous me senterial sarcoma in a
chicken and was shown to cause sarcomas which could be distinguished
histologically from the growths induced by RSV (Carr and Campbell
1958). The virus belongs to envelope subgroups A and B (Payne and
Biggs 1966; Duff and Vogt 1969). PRCII causes only sarcomas in chickens,
and compared to RSV, it is a less virulent agent: Of 50 chickens
inoculated with about 104 focus-forming units of virus, only 13
came down with tumors within an observation time of 4 weeks. In
chick embryo fibroblast cultures PRCII induced foci of predominantly
fusiform transformed cells; but no transformation was seen in cultures
of hematopoietic cells derived from chicken bone marrow or chicken
embryo yolk sac. Infectious center tests showed that while a focus
of PRCII -transformed cells could be induced by a single particle,
a focus which also released infectious progeny was the result of
double infection with transforming virus and nontransforming helper
virus. PRCII-transformed cells which failed to release infectious
virus have been isolated. Such nonproducer lines also failed to
produce noninfectious virions, an indication that the replication
defects in PRCII extend into the gag gene (Bister et al. 1977; Bister
and Vogt 1978; Hu et al. 1978; Hu and Vogt 1979). Superinfection
of these nonproducing cells with avian leukosis helper viruses led
to the rescue of infectious PRCII. In order to search for virus-specific
products in PRCII-transformed cells, virus producing and nonproducing
transformed fibroblasts were labeled with [35S]methionine (50 to
20 µCi/ml) and tested in immunoprecipitation using a variety of
antisera. The precipitates were resolved by polyacrylamide gel electro
phoresis and analyzed by autoradiography (Fig. I ). Rabbit sera
prepared against whole virions of the Prague strain of RSV and sera
against the structural gag protein of avian leukosis viruses precipitated
from PRCII transformed cell lysates a virus-specific protein
Fig. 1. Immunoprecipitation of virus-specific proteins
in PRCII-transformed producing and nonproducing cell clones. Cells
were labeled with 35S]methionine and proteins resolved on a 6 %-18
% SDS-polyacrylamide slab gel (Breitman et al. 1981 ). Cell lysates
and precipitating sera were: PRCII transformed producing cells with
(a) normal rabbit serum, (b) anti-whole virus serum; and PRCIItransformed
nonproducing clone with (c) anti-whole virus serum, (d) anti-p27
serum, (e) RSV tumorbearing rabbit serum preabsorbed with disrupted
whole virus, and (i) anti glycoprotein serum
of about Mr 105,000 (p105). In nonproducer cells this was the only
virus-specific product that could be identified. PI 05 was not found
in cells infected by nontransforming PRCII -associated helper virus.
Lysates of PRCII nonproducer cells did not react with sera directed
against the group-specific determinants of the virion surface glycoprotein
and against the virion polymerase. There also was no immunologic
cross reaction between p 105 and a broadly reacting rabbit anti-p60src
serum nor did such a serum precipitate another protein from PRCIl-transformed
celllysates. Therefore, we conclude that PRCII does not code for
a functional env or pol gene product and that although PRCII is
a pure sarcoma virus, it does not produce a transformation-specific
protein that cross reacts in immunoprecipitation with antisera against
p60src of RSV. The pI05 does, however, contain gag-related sequences.
But since gag codes for a protein of only Mr 76,000, pI05 must contain
additional non-gag sequences, provided its gag portion is not reiterated.
A more detailed structural characterization of p 105 was based on
two-dimensional tryptic peptide analysis, using [35S Jmethionine
as a label. A comparison of the peptide maps of Pr76gag and of p105
indicated that some but
Fig. 2. Tryptic peptide maps of PRCII p 105 and of Pr76
of PRCII-AV. [35S]methionine-labeled proteins were separated by
PAGE and located by autoradiography. The bands were excised and
the proteins eluted and oxidized with performic acid and digested
with TPCK-trypsin. The resultant peptides were separated by TLC
electrophoresis (pyridine : acetic acid, pH 4.5) at 600 V for lOO
min and by chromatography for 4 h in n-butanol : acetic acid: pyridine:water
(75: 15 :60:60)
not all of the gagpeptides were present in pI 05 and that pI 05
contained additional peptides not seen in Pr76gag (Fig. 2). Petide
maps of the individual gag proteins p19, p27, and p15 were also
obtained. The fourth gag protein, p12, does not contain useful [35SJmethionine
peptides. These maps of three individual gag proteins showed that
all of the p19 and p27 but none of the p 15 peptides were present
in pI 05. Identification of the common peptides was confirmed by
appropriate mixing experiments. These results lead to the conclusion
that p 105 contains the 5 I portion of the gag gene encompassing
p19 and p27 but lacks the 3' of gag with p15. No statement can be
made concerning the presence or absence of p12 sequences in p105.
However, we found a rabbit antiserum prepared against p27 which
did not react with p105, although it precipitated p27. Therefore,
not all of the determinants of p27 appear to be present in p105.
If the order of the gag proteins is N-pI9-p27-pI2-p15-C (Shealy
et al. 1980), then p105 may lack p12 and p15 together with a portion
from the carboxyterminus of p27. The gag-related part of p105 can
then account for roughly half of the p105 molecule. In order to
test for the possiblity that the remainder of p105 contains partial,
immunologically nonreactive sequencesderived from the pol or env
genes, tryptic peptide maps of gPr95env and of Pr180gag-pol of the
PRCII helper virus were prepared. There was no overlap between any
of the gPr95env peptides and those of pI 05. Of the pol peptides
in Pr180, one comigrated with a peptide of p105, and this observation
was confirmed in a mixing experiment. However, considering the relative
complexity of the PrI80 map, this overlap may be fortuitous and
requires further examination. We conclude that p105 does not contain
significant portions of the helper virus env or pol genes. Two-dimensional
tryptic maps were also obtained of the transformation-specific proteins
of (pI10), of carcinoma virus MH2 (p100), of avian erythroblastosis
virus AEV strain ES-4 (p75 and p40), and of the p60sre protein from
several genetically distinct lines of the Schmidt-Ruppin strain
of RSV as well as of the endogenous p60sre of chicken cells. The
p60src proteins, the AEV p40, and the non- gag portions of AEV p75,
MC29 p110, and MH2 p100 did not contain peptides coinciding with
any of p105. We conclude that PRCII contains new transformation-specific
sequences not found in RSV or in avian acute leukemia viruses AEV,
MC29, or MH2. Cells transformed by PRCII were labeled with (32p]orthophosphate
(1 mCi/ml) and followed by analysis by immunoprecipitation with
anti-virion sera. Electrophoresis and autoradiography indicated
that p 105 was heavily phosphorylated. This degree of phosphorylation
was greater than could be accounted for by the presence of the phosphorylated
gag protein p19 in pI 05. The most abundant phosphoamino acid in
p105 was tyrosine. These observations suggest that pl05 is phosphorylated
in its non- gag portion, probably at one or several tyrosine residues.
In order to test for phosphokinase activity associated with p105,
immunoprecipitates were incubated with (32p]ATP according to published
procedures before immunoprecipitation, electrophoresis, and autoradiography.
Under these conditions both pl05 and the heavy chain of IgG were
phos phorylated. We suggest that p105 is a phosphoprotein with associated
kinase activity capable of autophosphorylation and of phosphorylating
homologous IgG.
D. Discussion
PRCII is a representative of a new class of avian sarcoma viruses
that lack src, have a genetic structure similar to avian acute leukemia
viruses, and code for a transformation-specific gag-related polyprotein.
Other members of this class are FSV and avian sarcoma virus Y73
(Hanafusa et al. 1980 ; Kawai et al. 1980; Lee et al. 1980). FSVand
Y73 have been shown to contain a small (26 S) RNA genome. Our preliminary
data suggest that the genome of PRCII has also a size of about 26
S. PRCII and FSV habe some common transformation-specific sequences
as detected by nucleic acid hybridization (Shibuya et al. 1980),
and the proposal has been made to refer to these sequences as Ips
(FSV, PRCII Sarcoma) (1. Coffin et al. to be published). Y73 appears
to have no appreciable sequence relationship in its transformation-specific
in formation to either PRCII, FSV, or RSV (Shibuya et al. 1980;
M. Yoshida et al. 1980, personal communications). The transformation-specific
sequences of FSV have also been found to be related to those of
the SnyderTheilen and Gardner- Arnstein strains of feline sarcoma
virus (Shibuya et al. 1980; Barbacid et al. 1981). Since the latter
sequences have been detected in normal feline cells where they code
for a cellular protein homologue (Barbacid et al. 1981) one can
expect Ips to be also cell derived. The transformation-specific
polyproteins of FSV, Y73, PRCII, and feline sarcoma virus are all
phosphorylated and show phosphokinase activity. The predominant
phosphoacceptor for these polyproteins is tyrosine (Hanafusa et
al. 1980; Kawai et al. 1980; Neil et al.1981 ; Barbacid et al. 1980).
For PRCII and the Snyder- Theilen strain of feline sarcoma virus
it has also been shown that phosphotyrosine levels in transformed
cells are substantially increased over normal cells (Barbacid et
al. 1980; K. Beemon 1980, personal communication). Phosphorylation
and kinase activity are also characteristic of p60src, and cells
transformed by RSV contain elevated levels of phosphotyrosine (
Collett and Erikson 1978; Levinson et al. 1978; Hunter and Sefton
1980). These parallels suggest that even though sarcoma viruses
may carry different transforming genes, the mechanisms of viral
sarcomagenesis could share common elements in protein function and
cellular targets.
Acknowledgment
Supported by U.S. Public Health Service Research Grants No. CA
1 3213 and 19725 awarded by the National Cancer Institute.
References
- Barbacid M, Beemon K, Devare SG (1980) Proc Natl Acad Sci USA
77:5158-5162
- Barbacid M, Lauver AV, Devare SG (1980) J Viro] 33: 196-207
- Barbacid M, Breitmann ML, Lauver A V, Long LK, Vogt PK (1981)
Virology 110:411-419
- Bister K, Hayman MJ, Vogt PK (1977) Virology 82:431-448
- Bister K, Vogt PK (1978) Virology 88:213-221- Breitman ML, Neil
JC, Moscovici C, Vogt PK (1981) Virology 108: 1-12
- Brugge JS, Erikson RL (1977) Nature 269:346-348 -CarrJG, Campbell
JG (1958) Brit J Cancer 12:631-635
- Collett MS, Erikson RL (1978) Proc Nat] Acad Sci USA 75: 2021-2024
- Duesberg PH, Vogt PK (1970) Proc Natl Acad Sci USA 67: 1673-1680
- Duff R, Vogt PK (1969) Virology 39: 18-30- Graf T (1975) Z Naturforsch
30 :847-849
- Hanafusa T, Wang L-H, Anderson SM, Karess RE, Hayward W, Hanafusa
H (1980) Proc Nat] Acad Sci USA 77:3009-3013
- Hu SSF, Moscovici C, Vogt PK (1978) Virology 89:162-178
- Hu SSF, Vogt PK (1979) Virology 92:278-284- Ishizaki R, Shimizu
T (1970) Cancer Res 30:2827-2831
- Hunter T, Sefton BM (1980) Proc Natl Acad Sci USA 77:1311-1315
- Kawai S, Yoshida M, Segawa K, Sugiyama H, Ishizaki R, Toyoshima
K (1980) Proc Natl Acad Sci USA 77:6199-6203
- Lai MMC, Hu SSF, Vogt PK ( 1979) Virology 97: 366-377
- Lee WH, Bister K, Pawson A, Robins T, Moscovici C, Duesberg PH
(1980) Proc Natl Acad Sci USA 77:2018-2022
- Levinson AD, Oppermann H, Levintow L, Varmus HE, Bishop JM (1978)
Cell 15:561-572
- Manteuil-Brutlag S, Liu SI, Kaplan HS (1980) Cell 19:643-652
- Neil JC, Breitman ML, Vogt PK (1981) Virology 108:98-110
- Payne LN, Biggs PM (1966) Virology 29: 190-198
- Roussel M, Saule S, Lagrou C, Rommens C, Beug H, Graf T, Stehelin
D (1979) Nature 281 :452-455
- Shealy DJ, Mosser AG, Rueckert RR (1980) J Virol 34:431-437- SheinessD,
BishopJM(1979) J Virol 31:514-521
- Sheiness D, Bister K, Moscovici C, Fanshier L, Gonda T, Bishop
JM (1980) J Virol 33 :962-968
- Sherr CJ, Fedele LA, Oskarsson M, Maizel J, Vande Woude G (1980)
J Virol 34:200-212- Shibuya M, Hanafusa T, Hanafusa H, Stephenson
JR (1980) 77: 6536-6540
- Spector D, Varmus HE, Bishop JM (1978) Proc Natl Acad Sci USA
75:4102-4106
- Stehelin D, Varmus HE, Bishop JM, Vogt PK (1976) Nature 260: 170-173
- Van de Ven WJM, Khan AS, Reynolds FH jr , Mason KT, Stephenson
JR (1980) J Virol 33: 1034-1045
- WangL-H, Duesberg PH, Beemon K, Vogt PK (1975) J Virol16:1051-1070
-Witte ON, Rosenberg N, Paskind M, Shields A, Baltimore D (1978)
Proc Natl Acad Sci USA 75:2488-2492
|